Atlas Trials

Safety Study Of Chemotherapy Combined With Dendritic Cell Vaccine to Treat Breast Cancer

Clinical trial NCT02018458 · COMPLETED

Trial details

NCT number
NCT02018458
Sponsor
Baylor Research Institute
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2014-05-01
Primary completion
2019-09-18
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.